APO Research
Talk to an analyst

APO RESEARCH · REPORT

Generic Sterile Injectable

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Generic Sterile Injectable Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchGeneric Sterile Injectable Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Generic Sterile Injectable Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Generic Sterile Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Generic Sterile Injectable Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Generic Sterile Injectable Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Generic Sterile Injectable market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Generic Sterile Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Generic Sterile Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Generic Sterile Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Generic Sterile Injectable include 3M, Teva, Sun Pharma, Mylan, Fresenius Kabi, Baxter Inc, AstraZeneca Plc, Pfizer/Hospira and Novartis/Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Generic Sterile Injectable market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Generic Sterile Injectable market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Generic Sterile Injectable market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Generic Sterile Injectable.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Generic Sterile Injectable market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Generic Sterile Injectable Market by Company

3M

Teva

Sun Pharma

Mylan

Fresenius Kabi

Baxter Inc

AstraZeneca Plc

Pfizer/Hospira

Novartis/Sandoz

Merck & Co., Inc

Hikma

Hellberg Safety Ab

Dr. Reddy’s

Generic Sterile Injectable Segment by Type

Monoclonal Antibodies

Peptide Hormones

Cytokines

Insulin

Vaccines

Others

Generic Sterile Injectable Segment by Application

Hospitals

Pharmacies

Online Pharmacies

Generic Sterile Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Sterile Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Generic Sterile Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Sterile Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Generic Sterile Injectable manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Generic Sterile Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monoclonal Antibodies Table 2. Major Company of Peptide Hormones Table 3. Major Company of Cytokines Table 4. Major Company of Insulin Table 5. Major Company of Vaccines Table 6. Major Company of Others Table 7. Global Generic Sterile Injectable Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 9. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2021-2026) Table 10. Global Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 11. Global Generic Sterile Injectable Sales Market Share in Value by Type (2021-2026) Table 12. Global Generic Sterile Injectable Price by Type (2021-2026) & (US$/unit) Table 13. Global Generic Sterile Injectable Sales by Type (2027-2032) & (k units) Table 14. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2027-2032) Table 15. Global Generic Sterile Injectable Sales by Type (2027-2032) & (US$ Million) Table 16. Global Generic Sterile Injectable Sales Market Share in Value by Type (2027-2032) Table 17. Global Generic Sterile Injectable Price by Type (2027-2032) & (US$/unit) Table 18. North America Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 19. North America Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 21. Europe Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 25. Latin America Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Generic Sterile Injectable Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Generic Sterile Injectable Sales by Type (2021-2026) & (US$ Million) Table 28. Generic Sterile Injectable Industry Trends Table 29. Generic Sterile Injectable Industry Drivers Table 30. Generic Sterile Injectable Industry Opportunities and Challenges Table 31. Generic Sterile Injectable Industry Restraints Table 32. Global Generic Sterile Injectable Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Generic Sterile Injectable Revenue Market Share by Company (2021-2026) Table 34. Global Generic Sterile Injectable Sales by Company (2021-2026) & (k units) Table 35. Global Generic Sterile Injectable Sales Share by Company (2021-2026) Table 36. Global Generic Sterile Injectable Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Generic Sterile Injectable Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Generic Sterile Injectable Major Company Production Sites and Headquarters Table 39. Global Generic Sterile Injectable Company, Product Type & Application Table 40. Global Generic Sterile Injectable Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Generic Sterile Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Generic Sterile Injectable Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Generic Sterile Injectable Sales by Region (2021-2026) & (k units) Table 45. Global Generic Sterile Injectable Sales Market Share in Volume by Region (2021-2026) Table 46. Global Generic Sterile Injectable Sales by Region (2021-2026) & (US$ Million) Table 47. Global Generic Sterile Injectable Sales Market Share in Value by Region (2021-2026) Table 48. Global Generic Sterile Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Generic Sterile Injectable Sales by Region (2027-2032) & (k units) Table 50. Global Generic Sterile Injectable Sales Market Share in Volume by Region (2027-2032) Table 51. Global Generic Sterile Injectable Sales by Region (2027-2032) & (US$ Million) Table 52. Global Generic Sterile Injectable Sales Market Share in Value by Region (2027-2032) Table 53. Global Generic Sterile Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Generic Sterile Injectable Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 56. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2021-2026) Table 57. Global Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 58. Global Generic Sterile Injectable Sales Market Share in Value by Application (2021-2026) Table 59. Global Generic Sterile Injectable Price by Application (2021-2026) & (US$/unit) Table 60. Global Generic Sterile Injectable Sales by Application (2027-2032) & (k units) Table 61. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2027-2032) Table 62. Global Generic Sterile Injectable Sales by Application (2027-2032) & (US$ Million) Table 63. Global Generic Sterile Injectable Sales Market Share in Value by Application (2027-2032) Table 64. Global Generic Sterile Injectable Price by Application (2027-2032) & (US$/unit) Table 65. North America Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 66. North America Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 68. Europe Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 72. Latin America Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Generic Sterile Injectable Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Generic Sterile Injectable Sales by Application (2021-2026) & (US$ Million) Table 75. 3M Company Information Table 76. 3M Business Overview Table 77. 3M Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. 3M Generic Sterile Injectable Product Portfolio Table 79. 3M Recent Development Table 80. Teva Company Information Table 81. Teva Business Overview Table 82. Teva Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Teva Generic Sterile Injectable Product Portfolio Table 84. Teva Recent Development Table 85. Sun Pharma Company Information Table 86. Sun Pharma Business Overview Table 87. Sun Pharma Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Sun Pharma Generic Sterile Injectable Product Portfolio Table 89. Sun Pharma Recent Development Table 90. Mylan Company Information Table 91. Mylan Business Overview Table 92. Mylan Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Mylan Generic Sterile Injectable Product Portfolio Table 94. Mylan Recent Development Table 95. Fresenius Kabi Company Information Table 96. Fresenius Kabi Business Overview Table 97. Fresenius Kabi Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Fresenius Kabi Generic Sterile Injectable Product Portfolio Table 99. Fresenius Kabi Recent Development Table 100. Baxter Inc Company Information Table 101. Baxter Inc Business Overview Table 102. Baxter Inc Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Baxter Inc Generic Sterile Injectable Product Portfolio Table 104. Baxter Inc Recent Development Table 105. AstraZeneca Plc Company Information Table 106. AstraZeneca Plc Business Overview Table 107. AstraZeneca Plc Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. AstraZeneca Plc Generic Sterile Injectable Product Portfolio Table 109. AstraZeneca Plc Recent Development Table 110. Pfizer/Hospira Company Information Table 111. Pfizer/Hospira Business Overview Table 112. Pfizer/Hospira Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Pfizer/Hospira Generic Sterile Injectable Product Portfolio Table 114. Pfizer/Hospira Recent Development Table 115. Novartis/Sandoz Company Information Table 116. Novartis/Sandoz Business Overview Table 117. Novartis/Sandoz Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Novartis/Sandoz Generic Sterile Injectable Product Portfolio Table 119. Novartis/Sandoz Recent Development Table 120. Merck & Co., Inc Company Information Table 121. Merck & Co., Inc Business Overview Table 122. Merck & Co., Inc Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Merck & Co., Inc Generic Sterile Injectable Product Portfolio Table 124. Merck & Co., Inc Recent Development Table 125. Hikma Company Information Table 126. Hikma Business Overview Table 127. Hikma Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Hikma Generic Sterile Injectable Product Portfolio Table 129. Hikma Recent Development Table 130. Hellberg Safety Ab Company Information Table 131. Hellberg Safety Ab Business Overview Table 132. Hellberg Safety Ab Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Hellberg Safety Ab Generic Sterile Injectable Product Portfolio Table 134. Hellberg Safety Ab Recent Development Table 135. Dr. Reddy’s Company Information Table 136. Dr. Reddy’s Business Overview Table 137. Dr. Reddy’s Generic Sterile Injectable Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Dr. Reddy’s Generic Sterile Injectable Product Portfolio Table 139. Dr. Reddy’s Recent Development Table 140. North America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. North America Generic Sterile Injectable Sales by Country (2021-2026) & (k units) Table 142. North America Generic Sterile Injectable Sales Market Share by Country (2021-2026) Table 143. North America Generic Sterile Injectable Sales Forecast by Country (2027-2032) & (k units) Table 144. North America Generic Sterile Injectable Sales Market Share Forecast by Country (2027-2032) Table 145. North America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. North America Generic Sterile Injectable Market Size by Country (2021-2026) & (US$ Million) Table 147. North America Generic Sterile Injectable Market Share by Country (2021-2026) Table 148. North America Generic Sterile Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. North America Generic Sterile Injectable Market Share Forecast by Country (2027-2032) Table 150. Europe Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 151. Europe Generic Sterile Injectable Sales by Country (2021-2026) & (k units) Table 152. Europe Generic Sterile Injectable Sales Market Share by Country (2021-2026) Table 153. Europe Generic Sterile Injectable Sales Forecast by Country (2027-2032) & (k units) Table 154. Europe Generic Sterile Injectable Sales Market Share Forecast by Country (2027-2032) Table 155. Europe Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Europe Generic Sterile Injectable Market Size by Country (2021-2026) & (US$ Million) Table 157. Europe Generic Sterile Injectable Market Share by Country (2021-2026) Table 158. Europe Generic Sterile Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Europe Generic Sterile Injectable Market Share Forecast by Country (2027-2032) Table 160. Asia-Pacific Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 161. Asia-Pacific Generic Sterile Injectable Sales by Country (2021-2026) & (k units) Table 162. Asia-Pacific Generic Sterile Injectable Sales Market Share by Country (2021-2026) Table 163. Asia-Pacific Generic Sterile Injectable Sales Forecast by Country (2027-2032) & (k units) Table 164. Asia-Pacific Generic Sterile Injectable Sales Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Generic Sterile Injectable Market Size by Country (2021-2026) & (US$ Million) Table 167. Asia-Pacific Generic Sterile Injectable Market Share by Country (2021-2026) Table 168. Asia-Pacific Generic Sterile Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Asia-Pacific Generic Sterile Injectable Market Share Forecast by Country (2027-2032) Table 170. Latin America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 171. Latin America Generic Sterile Injectable Sales by Country (2021-2026) & (k units) Table 172. Latin America Generic Sterile Injectable Sales Market Share by Country (2021-2026) Table 173. Latin America Generic Sterile Injectable Sales Forecast by Country (2027-2032) & (k units) Table 174. Latin America Generic Sterile Injectable Sales Market Share Forecast by Country (2027-2032) Table 175. Latin America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Latin America Generic Sterile Injectable Market Size by Country (2021-2026) & (US$ Million) Table 177. Latin America Generic Sterile Injectable Market Share by Country (2021-2026) Table 178. Latin America Generic Sterile Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Latin America Generic Sterile Injectable Market Share Forecast by Country (2027-2032) Table 180. Middle East and Africa Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 181. Middle East and Africa Generic Sterile Injectable Sales by Country (2021-2026) & (k units) Table 182. Middle East and Africa Generic Sterile Injectable Sales Market Share by Country (2021-2026) Table 183. Middle East and Africa Generic Sterile Injectable Sales Forecast by Country (2027-2032) & (k units) Table 184. Middle East and Africa Generic Sterile Injectable Sales Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Generic Sterile Injectable Market Size by Country (2021-2026) & (US$ Million) Table 187. Middle East and Africa Generic Sterile Injectable Market Share by Country (2021-2026) Table 188. Middle East and Africa Generic Sterile Injectable Market Size Forecast by Country (2027-2032) & (US$ Million) Table 189. Middle East and Africa Generic Sterile Injectable Market Share Forecast by Country (2027-2032) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Generic Sterile Injectable Distributors List Table 193. Generic Sterile Injectable Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Generic Sterile Injectable Image Figure 2. Global Generic Sterile Injectable Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Generic Sterile Injectable Market Size (2021-2032) & (US$ Million) Figure 4. Global Generic Sterile Injectable Sales (2021-2032) & (k units) Figure 5. Monoclonal Antibodies Image Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (k units) Figure 7. Peptide Hormones Image Figure 8. Global Peptide Hormones Sales YoY Growth (2021-2032) & (k units) Figure 9. Cytokines Image Figure 10. Global Cytokines Sales YoY Growth (2021-2032) & (k units) Figure 11. Insulin Image Figure 12. Global Insulin Sales YoY Growth (2021-2032) & (k units) Figure 13. Vaccines Image Figure 14. Global Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Generic Sterile Injectable Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Generic Sterile Injectable Market Share by Type 2025 VS 2032 Figure 19. North America Generic Sterile Injectable Sales Market Share in Volume by Type in 2025 Figure 20. North America Generic Sterile Injectable Sales Market Share in Value by Type in 2025 Figure 21. Europe Generic Sterile Injectable Sales Market Share in Volume by Type in 2025 Figure 22. Europe Generic Sterile Injectable Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Type in 2025 Figure 25. Latin America Generic Sterile Injectable Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Generic Sterile Injectable Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Generic Sterile Injectable Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Generic Sterile Injectable Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Pharmacies Image Figure 34. Global Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Online Pharmacies Image Figure 36. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Generic Sterile Injectable Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Generic Sterile Injectable Market Share by Application 2025 VS 2032 Figure 39. North America Generic Sterile Injectable Sales Market Share in Volume by Application in 2025 Figure 40. North America Generic Sterile Injectable Sales Market Share in Value by Application in 2025 Figure 41. Europe Generic Sterile Injectable Sales Market Share in Volume by Application in 2025 Figure 42. Europe Generic Sterile Injectable Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Application in 2025 Figure 45. Latin America Generic Sterile Injectable Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Generic Sterile Injectable Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Generic Sterile Injectable Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Application in 2025 Figure 49. North America Generic Sterile Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Generic Sterile Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Generic Sterile Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Generic Sterile Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Generic Sterile Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Generic Sterile Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Generic Sterile Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Generic Sterile Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Generic Sterile Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Generic Sterile Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Generic Sterile Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Generic Sterile Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Generic Sterile Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Generic Sterile Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Generic Sterile Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Generic Sterile Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Generic Sterile Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Generic Sterile Injectable Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Generic Sterile Injectable Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Generic Sterile Injectable Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Generic Sterile Injectable Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Generic Sterile Injectable Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Peptide Hormones
  • Cytokines
  • Insulin
  • Vaccines
  • Others
Applications
  • Hospitals
  • Pharmacies
  • Online Pharmacies
Companies covered
  • 3M
  • Teva
  • Sun Pharma
  • Mylan
  • Fresenius Kabi
  • Baxter Inc
  • AstraZeneca Plc
  • Pfizer/Hospira
  • Novartis/Sandoz
  • Merck & Co., Inc
  • Hikma
  • Hellberg Safety Ab
  • Dr. Reddy’s

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Generic Sterile Injectable Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Generic Sterile Injectable Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Generic Sterile Injectable Market by Type
  6. 1.3.1 Monoclonal Antibodies
  7. 1.3.2 Peptide Hormones
  8. 1.3.3 Cytokines
  9. 1.3.4 Insulin
  10. 1.3.5 Vaccines
  11. 1.3.6 Others
  12. 1.4 Global Generic Sterile Injectable Market Size by Type
  13. 1.4.1 Global Generic Sterile Injectable Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Generic Sterile Injectable Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Generic Sterile Injectable Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Generic Sterile Injectable Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Generic Sterile Injectable Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Generic Sterile Injectable Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Generic Sterile Injectable Industry Trends
  2. 2.2 Generic Sterile Injectable Industry Drivers
  3. 2.3 Generic Sterile Injectable Industry Opportunities and Challenges
  4. 2.4 Generic Sterile Injectable Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Generic Sterile Injectable Revenue (2021-2026)
  2. 3.2 Global Top Players by Generic Sterile Injectable Sales (2021-2026)
  3. 3.3 Global Top Players by Generic Sterile Injectable Price (2021-2026)
  4. 3.4 Global Generic Sterile Injectable Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Generic Sterile Injectable Major Company Production Sites & Headquarters
  6. 3.6 Global Generic Sterile Injectable Company, Product Type & Application
  7. 3.7 Global Generic Sterile Injectable Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Generic Sterile Injectable Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Generic Sterile Injectable Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Generic Sterile Injectable Tier 1, Tier 2, and Tier 3
4 Generic Sterile Injectable Regional Status and Outlook
  1. 4.1 Global Generic Sterile Injectable Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Generic Sterile Injectable Historic Market Size by Region
  3. 4.2.1 Global Generic Sterile Injectable Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Generic Sterile Injectable Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Generic Sterile Injectable Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Generic Sterile Injectable Forecasted Market Size by Region
  7. 4.3.1 Global Generic Sterile Injectable Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Generic Sterile Injectable Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Generic Sterile Injectable Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Generic Sterile Injectable by Application
  1. 5.1 Generic Sterile Injectable Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Generic Sterile Injectable Market Size by Application
  6. 5.2.1 Global Generic Sterile Injectable Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Generic Sterile Injectable Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Generic Sterile Injectable Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Generic Sterile Injectable Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Generic Sterile Injectable Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Generic Sterile Injectable Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 3M
  2. 6.1.1 3M Company Information
  3. 6.1.2 3M Business Overview
  4. 6.1.3 3M Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 3M Generic Sterile Injectable Product Portfolio
  6. 6.1.5 3M Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Generic Sterile Injectable Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma Generic Sterile Injectable Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Generic Sterile Injectable Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Generic Sterile Injectable Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Baxter Inc
  32. 6.6.1 Baxter Inc Company Information
  33. 6.6.2 Baxter Inc Business Overview
  34. 6.6.3 Baxter Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Inc Generic Sterile Injectable Product Portfolio
  36. 6.6.5 Baxter Inc Recent Developments
  37. 6.7 AstraZeneca Plc
  38. 6.7.1 AstraZeneca Plc Company Information
  39. 6.7.2 AstraZeneca Plc Business Overview
  40. 6.7.3 AstraZeneca Plc Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Plc Generic Sterile Injectable Product Portfolio
  42. 6.7.5 AstraZeneca Plc Recent Developments
  43. 6.8 Pfizer/Hospira
  44. 6.8.1 Pfizer/Hospira Company Information
  45. 6.8.2 Pfizer/Hospira Business Overview
  46. 6.8.3 Pfizer/Hospira Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer/Hospira Generic Sterile Injectable Product Portfolio
  48. 6.8.5 Pfizer/Hospira Recent Developments
  49. 6.9 Novartis/Sandoz
  50. 6.9.1 Novartis/Sandoz Company Information
  51. 6.9.2 Novartis/Sandoz Business Overview
  52. 6.9.3 Novartis/Sandoz Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis/Sandoz Generic Sterile Injectable Product Portfolio
  54. 6.9.5 Novartis/Sandoz Recent Developments
  55. 6.10 Merck & Co., Inc
  56. 6.10.1 Merck & Co., Inc Company Information
  57. 6.10.2 Merck & Co., Inc Business Overview
  58. 6.10.3 Merck & Co., Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck & Co., Inc Generic Sterile Injectable Product Portfolio
  60. 6.10.5 Merck & Co., Inc Recent Developments
  61. 6.11 Hikma
  62. 6.11.1 Hikma Company Information
  63. 6.11.2 Hikma Business Overview
  64. 6.11.3 Hikma Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hikma Generic Sterile Injectable Product Portfolio
  66. 6.11.5 Hikma Recent Developments
  67. 6.12 Hellberg Safety Ab
  68. 6.12.1 Hellberg Safety Ab Company Information
  69. 6.12.2 Hellberg Safety Ab Business Overview
  70. 6.12.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hellberg Safety Ab Generic Sterile Injectable Product Portfolio
  72. 6.12.5 Hellberg Safety Ab Recent Developments
  73. 6.13 Dr. Reddy’s
  74. 6.13.1 Dr. Reddy’s Company Information
  75. 6.13.2 Dr. Reddy’s Business Overview
  76. 6.13.3 Dr. Reddy’s Generic Sterile Injectable Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dr. Reddy’s Generic Sterile Injectable Product Portfolio
  78. 6.13.5 Dr. Reddy’s Recent Developments
7 North America by Country
  1. 7.1 North America Generic Sterile Injectable Sales by Country
  2. 7.1.1 North America Generic Sterile Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Generic Sterile Injectable Sales by Country (2021-2026)
  4. 7.1.3 North America Generic Sterile Injectable Sales Forecast by Country (2027-2032)
  5. 7.2 North America Generic Sterile Injectable Market Size by Country
  6. 7.2.1 North America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Generic Sterile Injectable Market Size by Country (2021-2026)
  8. 7.2.3 North America Generic Sterile Injectable Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Generic Sterile Injectable Sales by Country
  2. 8.1.1 Europe Generic Sterile Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Generic Sterile Injectable Sales by Country (2021-2026)
  4. 8.1.3 Europe Generic Sterile Injectable Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Generic Sterile Injectable Market Size by Country
  6. 8.2.1 Europe Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Generic Sterile Injectable Market Size by Country (2021-2026)
  8. 8.2.3 Europe Generic Sterile Injectable Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Generic Sterile Injectable Sales by Country
  2. 9.1.1 Asia-Pacific Generic Sterile Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Generic Sterile Injectable Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Generic Sterile Injectable Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Generic Sterile Injectable Market Size by Country
  6. 9.2.1 Asia-Pacific Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Generic Sterile Injectable Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Generic Sterile Injectable Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Generic Sterile Injectable Sales by Country
  2. 10.1.1 South America Generic Sterile Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Generic Sterile Injectable Sales by Country (2021-2026)
  4. 10.1.3 South America Generic Sterile Injectable Sales Forecast by Country (2027-2032)
  5. 10.2 South America Generic Sterile Injectable Market Size by Country
  6. 10.2.1 South America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Generic Sterile Injectable Market Size by Country (2021-2026)
  8. 10.2.3 South America Generic Sterile Injectable Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Generic Sterile Injectable Sales by Country
  2. 11.1.1 Middle East and Africa Generic Sterile Injectable Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Generic Sterile Injectable Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Generic Sterile Injectable Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Generic Sterile Injectable Market Size by Country
  6. 11.2.1 Middle East and Africa Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Generic Sterile Injectable Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Generic Sterile Injectable Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Generic Sterile Injectable Value Chain Analysis
  2. 12.1.1 Generic Sterile Injectable Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Generic Sterile Injectable Production Mode & Process
  7. 12.2 Generic Sterile Injectable Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Generic Sterile Injectable Distributors
  10. 12.2.3 Generic Sterile Injectable Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst